| Literature DB >> 10522708 |
J Wouters1, F Durant, B Masereel.
Abstract
The crystal structure of seratrodast (AA-2414), a potent thromboxane A2 (TXA2) receptor antagonist, served as starting point to docking studies with the modeled human TXA2 receptor. This structural approach provides rational basis for the design of new antagonists within the aryl sulfonamide family.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10522708 DOI: 10.1016/s0960-894x(99)00490-4
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823